BerGenBio ASA (FRA:7BG0) 1-Year Share Buyback Ratio : -45.40% (As of Dec. 2024 )

View and export this data going back to 2019. Start your Free Trial

What is BerGenBio ASA 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. BerGenBio ASA's current 1-Year Share Buyback Ratio was -45.40%.

FRA:7BG0's 1-Year Share Buyback Ratio is ranked worse than
76.14% of 1207 companies
in the Biotechnology industry
Industry Median: -13.6 vs FRA:7BG0: -45.40

Competitive Comparison of BerGenBio ASA's 1-Year Share Buyback Ratio

For the Biotechnology subindustry, BerGenBio ASA's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BerGenBio ASA's 1-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BerGenBio ASA's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where BerGenBio ASA's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

BerGenBio ASA 1-Year Share Buyback Ratio Calculation

BerGenBio ASA's 1-Year Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2023 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Dec. 2023 )
	=	(26.887	-	39.087)	/	26.887
	=	-45.4%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BerGenBio ASA (FRA:7BG0) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

BerGenBio ASA 1-Year Share Buyback Ratio Related Terms

BerGenBio ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (FRA:7BG0) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

BGBIO:Norway 0RU5:UK

Address

Mollendalsbakken 9, Bergen, NOR, 5009

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.

BerGenBio ASA Headlines

No Headlines